JAN 04, 2016 12:29 PM PST

'STING' Pathway Inhibited By Colorectal Cancer Cells

WRITTEN BY: Kara Marker
The stimulator of interferon genes (STING) pathway, discovered in 2008 to promote type 1 interferon production in response to a pathogenic infection, was recently found to also play a role in suppressing colorectal cancer cells (Journal of Molecular Cell Biology). Many populations of abnormally growing tumor cells inhibit STING in order to avoid immune system detection.

Type 1 interferons play a multi-faceted role in activate both the innate and adaptive immune system; interferon-related production of various cells reduces tissue damage during infection and prevents autoimmune activity (Nature Reviews Immunology). From the Sylvester Comprehensive Center at the University of Miami Miller School of Medicine, scientists investigate the role of the STING pathway in controlling cells like type 1 interferons during cases of colorectal cancer. Their study was recently published in Cell Reports.

Almost all cases of colorectal cancers are adenocarnomas that begin growth in glandular cells inside the colon or rectum. Although the death rate from colorectal cancer has been steadily dropping during the past two decades, about 50,000 people died from this cancer in 2015 (American Cancer Society). 
 

Researchers used a technique called “epigenetic hypermethylation” to mute the effect of STING signaling in order to replicate and visualize how colorectal cancer cells grow and evade the immune system. They did this by adding a methyl group to STING-specific DNA to inhibit transcription (Nature).

Without properly functioning STING signaling, DNA-damaged cells went undetected by the body’s immune cells. Inhibition of the STING pathway prevented cytokine production, which resulted in decreased tissue repair and “anti-tumor cytotoxic T cell priming” (Cell). A loss of antigen-presenting cells called dendritic cells also occurs without STING signaling. Dendritic cells are needed to recognize tumor cells circulating in the blood stream.
 


If loss of STING activity leads to unrestrained cancer growth, shouldn’t scientists figure out a way to turn STING activity back on? This is certainly a potential answer for colorectal cancer, but scientists also have to consider the careful balance of STING activity that must be kept. Overstimulation of this pathway has numerous consequences such as autoinflammatory disease and “inflammation driven skin cancer” (Cell).

Source: Cell Reports
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 17, 2019
Immunology
SEP 17, 2019
Unconventional T Cells
Spondyloarthritis is one of the most common types of chronic joint inflammation affecting nearly 1-2 percent of the Western population. Scientists report that rare populations of unconvention...
SEP 17, 2019
Health & Medicine
SEP 17, 2019
The Role of the Gut-Lung Axis in the Development of Tuberculosis
Observations of the human microbiota date back as far as the 1680s when Antonie van Leeuwenhoek noted significant differences in the types of bacteria from...
SEP 17, 2019
Immunology
SEP 17, 2019
The C-word. Michael Kinch's new book and the future of Cancer Treatment
The C-word. Dare we say it? Is a cure for cancer within reach?   Professor Michael Kinch https://publichealth.wustl.edu/scholars/michael-s-kinch/ of W...
SEP 17, 2019
Microbiology
SEP 17, 2019
Dengue Vaccine Reaches the Clinic, with Restrictions
Dengue fever is an unusual virus that presented complications for the recently-developed and first vaccine for the disease....
SEP 17, 2019
Immunology
SEP 17, 2019
A Food Additive Could Make Your Cat Hypoallergenic
With 10-30% of the population reporting sensitivity to cat dander, you probably know someone with a cat allergy.  That's why scientists at Nestl&e...
SEP 17, 2019
Immunology
SEP 17, 2019
Making Opioids Safer
The opioid crisis results in 130 American deaths every day, and both prescribed and synthetic opioids are at the core of the epidemic.  Any other drug...
Loading Comments...